# Translational Potential of a Contrast Agent for FGS Applications in pNETs

**Authors:** Solmaz AghaAmiri, Jeannelyn S. Estrella, Servando Hernandez Vargas, Mark W. Hurd, Sukhen C. Ghosh, Ali Azhdarinia, Naruhiko Ikoma

PMC · DOI: 10.1007/s11307-024-01894-1 · Molecular Imaging and Biology · 2024-01-24

## Full-text entities

- **Genes:** SSTR2 (somatostatin receptor 2) [NCBI Gene 6752] {aka SST2}
- **Diseases:** FGS (MESH:D000267), pNET (MESH:D018242), Pancreatic neuroendocrine tumors (MESH:D018358), diabetes (MESH:D003920), cancer (MESH:D009369), endocrine insufficiency (MESH:D000309), ovarian cancer (MESH:D010051), TOC (MESH:C536164), exocrine insufficiency (MESH:D010188)
- **Chemicals:** folic acid (MESH:D005492), 68Ga-DOTA-TOC (MESH:C499142), 68Ga-DOTATATE (MESH:C513399), CYTALUX (MESH:C000720187), FGS (-), hematoxylin (MESH:D006416), H&E (MESH:D006371)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10973013/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10973013/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC10973013/full.md

---
Source: https://tomesphere.com/paper/PMC10973013